资讯
New NHS data suggests weight-loss jabs like Mounjaro could reduce sick days by a third and save taxpayers £5bn a year. But ...
Novo Nordisk's Wegovy has received accelerated approval for use in patients with metabolic dysfunction-associated ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果